Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
about
HDAC4 is expressed on multiple T cell lineages but dispensable for their development and function.Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacyTrichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.Is There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?The renaissance of anti-neoplastic immunity from tumor cell demise.Trichostatin A and 5-Aza-2'-Deoxycytidine influence the expression of cold-induced genes in Arabidopsis.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.
P2860
Q33566569-5A3ABE9F-9482-48C9-B483-5C9015C6D63BQ38749824-AC88CE5A-F09E-42A7-9C84-7AED1D9E9B85Q41664041-AEB1E233-5D29-4C0A-A30D-EF5399615FFDQ47110491-BEEB975C-8E04-478E-9D40-644CA0D611DEQ48193643-527F9F4F-A31D-4EA9-ADCD-D181589DE67CQ48632663-D95413B1-8840-4EE6-AF8C-4E12C9E4E790Q50075685-1F296D6E-AC15-4D60-82A7-0E5ADA57A04B
P2860
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
@en
type
label
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
@en
prefLabel
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
@en
P2860
P1476
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
@en
P2093
Irina V Tiper
P2860
P2888
P304
P356
10.1007/S00262-016-1900-Z
P50
P577
2016-09-10T00:00:00Z
P6179
1014829596